ORLANDINI MAURIZIO

Maurizio
Orlandini
Dipartimento di Biotecnologie, Chimica e Farmacia
Professore Associato

Office hours

  • Tuesday from 09:00 to 12:00
    Place: Ufficio A_03_53
    Note: Contattare preventivamente il docente

Office A_03_53

Contacts

maurizio.orlandini@unisi.it
0577232065 [int.2065]

Curriculum Vitae

cv

Teaching activities

Completion accademic year: 2025/2026

MOLECULAR BIOLOGY
Course year: 4 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2022/2023
MOLECULAR BIOLOGY OF CANCER
Course year: 1 Second cycle degree (Laurea Magistrale) SUSTAINABLE INDUSTRIAL PHARMACEUTICAL BIOTECHNOLOGY A.Y. 2025/2026
RATIONAL TREATMENT OF CANCER
Course year: 1 Second cycle degree (Laurea Magistrale) SUSTAINABLE INDUSTRIAL PHARMACEUTICAL BIOTECHNOLOGY A.Y. 2025/2026

Completion accademic year: 2024/2025

MOLECULAR BIOLOGY
Course year: 4 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2021/2022
MOLECULAR BIOLOGY OF CANCER
Course year: 1 Second cycle degree (Laurea Magistrale) SUSTAINABLE INDUSTRIAL PHARMACEUTICAL BIOTECHNOLOGY A.Y. 2024/2025

Completion accademic year: 2023/2024

MOLECULAR BIOLOGY
Course year: 4 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2020/2021
MOLECULAR BIOLOGY OF CANCER
Course year: 1 Second cycle degree (Laurea Magistrale) SUSTAINABLE INDUSTRIAL PHARMACEUTICAL BIOTECHNOLOGY A.Y. 2023/2024

Completion accademic year: 2022/2023

MOLECULAR BIOLOGY
Course year: 4 Full cicle (5 years) PHARMACEUTICAL CHEMISTRY AND TECHNOLOGY A.Y. 2019/2020
MOLECULAR BIOLOGY OF CANCER
Course year: 1 Second cycle degree (Laurea Magistrale) SUSTAINABLE INDUSTRIAL PHARMACEUTICAL BIOTECHNOLOGY A.Y. 2022/2023

Completion accademic year: 2021/2022

APPLIED BIOCHEMISTRY
Course year: 3 Full cicle (5 years) PHARMACY A.Y. 2019/2020

Registration for exams

Research

Ultime pubblicazioni:

  • Paolino, M., Tassone, G., Governa, P., Saletti, M., Lami, M., Carletti, R., et al. (2025). Morita−Baylis−Hillman Adduct Chemistry as a Tool for the Design
    of Lysine-Targeted Covalent Ligands. ACS MEDICINAL CHEMISTRY LETTERS [10.1021/acsmedchemlett.4c00479].     - view more
  • El-Khawaga, A.M., Orlandini, M., Raucci, L., Elmaghraby, K. (2025). Magnetic nanoparticles as a promising antimicrobial agent for combating multidrug resistant bacteria: a review. DISCOVER APPLIED SCIENCES, 7 [10.1007/s42452-025-06601-5]. - view more
  • El-Khawaga, A.M., Elmaghraby, K., Orlandini, M. (2025). Amoxicillin conjugated functionalized zinc ferrite nanoparticles for enhanced antibacterial, antibiofilm, and antioxidant activities. SCIENTIFIC REPORTS, 15(1), 24951 [10.1038/s41598-025-08782-w]. - view more
  • Frusciante, L., Nyong'A, C.N., Trezza, A., Shabab, B., Olmastroni, T., Barletta, R., et al. (2025). Bioactive Potential of Sweet Cherry (Prunus avium L.) Waste: Antioxidant and Anti-Inflammatory Properties for Sustainable Applications. FOODS, 14(9) [10.3390/foods14091523]. - view more
  • Raucci, L., Perrone, C.D., Barbera, S., de Boer, L.J., Tosi, G.M., Brunetti, J., et al. (2025). Structural and antigen-binding surface definition of an anti-CD93 monoclonal antibody for the treatment of degenerative vascular eye diseases. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 309(Pt 4) [10.1016/j.ijbiomac.2025.143118]. - view more
All publications